IRIS
SALA, GIANLUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.469
EU - Europa 1.037
AS - Asia 345
AF - Africa 2
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.857
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.468
IT - Italia 298
IE - Irlanda 295
SE - Svezia 184
CN - Cina 176
UA - Ucraina 85
TR - Turchia 67
DE - Germania 47
FR - Francia 47
IN - India 44
GB - Regno Unito 40
VN - Vietnam 35
BE - Belgio 12
FI - Finlandia 8
GR - Grecia 6
SG - Singapore 6
HK - Hong Kong 4
IL - Israele 3
JP - Giappone 3
NL - Olanda 3
BG - Bulgaria 2
CH - Svizzera 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
CA - Canada 1
CL - Cile 1
EG - Egitto 1
EU - Europa 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RS - Serbia 1
RU - Federazione Russa 1
Totale 2.857
Salva come PNG Salva come JPEG
Città #
Chandler 411
Dublin 292
Jacksonville 178
Princeton 114
Ashburn 91
Ann Arbor 85
Beijing 55
Chieti 54
Altamura 52
Nanjing 45
Dearborn 44
Izmir 36
Dong Ket 35
Wilmington 34
Southend 22
New York 21
Boardman 19
Washington 18
Cambridge 16
Los Angeles 16
Seattle 15
Nanchang 13
Pune 13
Brussels 12
Collecorvino 12
Hebei 11
Mcallen 10
Norwalk 10
Woodbridge 10
Pescara 9
Montesilvano 8
Shenyang 8
Falls Church 7
Milan 7
Fairfield 6
Tianjin 6
Finale Ligure 5
Kunming 5
Singapore 5
Zhengzhou 5
Hong Kong 4
Houston 4
Redwood City 4
Rome 4
Stockholm 4
Tappahannock 4
Changsha 3
Città Sant'Angelo 3
Hefei 3
Jiaxing 3
Jinan 3
Napoli 3
Tel Aviv 3
Valdagno 3
Andover 2
Cattolica 2
Chicago 2
Civitanova Marche 2
Dübendorf 2
Edinburgh 2
Frankfurt (Oder) 2
Fuzhou 2
Grevenbroich 2
Guangzhou 2
Kocaeli 2
Leinì 2
L’Aquila 2
Miami 2
Montesilvano Marina 2
Munich 2
Ningbo 2
San Jose 2
San Salvo 2
Sansepolcro 2
Sofia 2
Spoltore 2
Taipei 2
Taizhou 2
Vezzano sul Crostolo 2
Amsterdam 1
Ancona 1
Ardea 1
Atlanta 1
Auckland 1
Bangalore 1
Belgrade 1
Bovisio Masciago 1
Brescia 1
Budapest 1
Buenos Aires 1
Busso 1
Cairo 1
Catania 1
Changchun 1
Cislago 1
Clearwater 1
Corridonia 1
Dubai 1
Francavilla Al Mare 1
Frankfurt am Main 1
Totale 1.934
Salva come PNG Salva come JPEG
Nome #
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 112
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 91
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 91
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 88
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 88
ERBB3 BINDING ANTIBODY 85
ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs) 81
BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages 81
Therapeutic efficacy of the novel stimuli-sensitive nano-ferritins containing doxorubicin in a head and neck cancer model 81
Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer. 77
CAF-Derived IL6 and GM-CSF Cooperate to Induce M2-like TAMs–Letter 75
Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8(+) T cell number and tumour growth in pancreatic cancer 74
Development of an anti-BAG3 humanized antibody for treatment of pancreatic cancer 73
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes 73
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 73
The role of phospholipase Cγ1 in breast cancer and its clinical significance 68
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer 66
Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma 65
ABCC3 is a novel target for the treatment of pancreatic cancer 65
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine 63
Phospholipase Cgamma1 is required for metastasis development and progression 61
The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor 1 61
EV20, a Novel Anti-ErbB-3 Humanized Antibody, Promotes ErbB-3 Down-Regulation and Inhibits Tumor Growth In Vivo. 58
miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction. 58
Humanized anti-bag3 antibodies 57
HER3 targeting with an antibody-drug conjugate bypasses resistance to anti-HER2 therapies 56
LGALS3BP antibody-drug-conjugate and its use for the treatment of cancer 55
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer 52
The E27 β2-adrenergic receptor polymorphism reduces the risk of myocardial infarction in dyslipidemic young males 50
The role of phosphoinositide 3-kinase C2α in insulin signaling 49
Antibody-drug conjugates: The new frontier of chemotherapy 48
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 48
An ErbB-3 antibody, MP-RM-1, inhibits tumor growth by blocking ligand-dependent and independent activation of ErbB-3/Akt signaling. 48
EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer 47
HER-3: Hub for escape mechanisms 45
Feedback inhibition by RALT controls signal output by the ErbB network 45
Dual PDK1/aurora kinase a inhibitors reduce pancreatic cancer cell proliferation and colony formation 45
P63 role in breast cancer 44
Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control 44
BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration 41
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines 40
Negative regulation of receptor tyrosine kinase signals 39
Engineered human nanoferritin bearing the drug genz-644282 for cancer therapy 38
Role of BAG3 in cancer progression: A therapeutic opportunity 37
Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin 35
High activity and low toxicity of a novel CD71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors 33
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors 33
Concerted BAG3 and SIRPα blockade impairs pancreatic tumor growth 33
Breast cancer in the era of integrating "Omics" approaches 32
HPLC-DAD validated method for DM4 and its metabolite S-Me-DM4 quantification in biological matrix for clinical and pharmaceutical applications 29
A phosphoinositide 3-kinase/phospholipase cgamma1 pathway regulates fibroblast growth factor-induced capillary tube formation 29
Endosialin-binding antibody 27
USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer 26
MYC regulates metabolism through vesicular transfer of glycolytic kinases 25
Effects of an ErbB-3 antibody, MP-RM-1, on tumor growth and ligand-dependent and -independent activation of ErbB-3/akt signaling 19
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma 17
Therapeutic potential of antibody‐drug conjugate‐based therapy in head and neck cancer: A systematic review 14
Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans 14
Visualizing Galectin-3 Binding Protein Expression with ImmunoPET 13
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 13
Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target 10
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target 9
LGALS3BP is a potential target of antibody-drug conjugates in oral squamous cell carcinoma 9
Widespread in vivo efficacy of The-0504: A conditionally-activatable nanoferritin for tumor-agnostic targeting of CD71-expressing cancers 7
Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma 6
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma 6
Totale 3.175
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.579
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.579
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201974 0 0 0 0 0 0 0 0 0 9 16 49
2019/2020565 104 21 8 8 40 32 72 24 53 127 67 9
2020/2021337 39 3 60 7 23 60 24 15 16 34 9 47
2021/2022333 15 2 5 62 18 12 13 23 29 20 28 106
2022/20231.065 94 175 71 124 92 176 49 89 129 12 38 16
2023/2024549 38 15 64 33 36 214 97 26 5 21 0 0
Totale 3.175